Kevin J. Flessa
FDA investigator
Appears on 1 document from 2020, mostly at sites in New York. Most often cites design and construction features (21 CFR 211.42).
- 1
- Documents on file
- 17.0
- Observations per 483
- 2020
- First seen
- 2020
- Most recent
What they cite most
From 17 observations- 21 CFR 211.42Design and construction features3
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.142Warehousing procedures1
- 21 CFR 211.160General requirements1
- 21 CFR 211.165Testing and release for distribution1
Activity by year
2020: 1
Where
New York 1
Often inspects with
Is Kevin J. Flessa coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2020-06-25 | 483 Infusion Options, Inc.Jun 25, 2020 · Brooklyn, New York | Brooklyn, New York | 17 |
About this profile
What does Kevin J. Flessa inspect?
Kevin J. Flessa appears on 1 document on file covering 1 site, mostly in New York.
What do they cite most often?
21 CFR 211.42 (design and construction features), followed by 21 CFR 211.100 and 21 CFR 211.113.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Kevin J. Flessa is dated Jun 25, 2020.